Spruce Biosciences, Inc. (SPRB)
60.78
-2.52
(-3.98%)
USD |
NASDAQ |
Aug 28, 16:00
60.60
-0.18
(-0.30%)
After-Hours: 20:00
Spruce Biosciences Market Cap : 167.32M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 167.32M |
| August 27, 2026 | 174.25M |
| August 26, 2026 | 169.24M |
| August 25, 2026 | 174.53M |
| August 24, 2026 | 161.45M |
| August 21, 2026 | 141.99M |
| August 20, 2026 | 143.10M |
| August 19, 2026 | 145.79M |
| August 18, 2026 | 145.47M |
| August 17, 2026 | 145.68M |
| August 14, 2026 | 144.91M |
| August 13, 2026 | 137.01M |
| August 12, 2026 | 129.57M |
| August 11, 2026 | 127.76M |
| August 10, 2026 | 127.18M |
| August 07, 2026 | 129.02M |
| August 06, 2026 | 63.70M |
| August 05, 2026 | 63.96M |
| August 04, 2026 | 63.48M |
| August 03, 2026 | 59.20M |
| July 31, 2026 | 58.78M |
| July 30, 2026 | 59.52M |
| July 29, 2026 | 56.88M |
| July 28, 2026 | 57.09M |
| July 27, 2026 | 57.62M |
| Date | Value |
|---|---|
| July 24, 2026 | 59.12M |
| July 23, 2026 | 61.74M |
| July 22, 2026 | 61.20M |
| July 21, 2026 | 62.69M |
| July 20, 2026 | 61.07M |
| July 17, 2026 | 59.75M |
| July 16, 2026 | 60.77M |
| July 15, 2026 | 62.36M |
| July 14, 2026 | 63.62M |
| July 13, 2026 | 66.39M |
| July 10, 2026 | 68.71M |
| July 09, 2026 | 71.00M |
| July 08, 2026 | 68.34M |
| July 07, 2026 | 69.67M |
| July 06, 2026 | 71.15M |
| July 02, 2026 | 72.06M |
| July 01, 2026 | 72.11M |
| June 30, 2026 | 74.10M |
| June 29, 2026 | 76.68M |
| June 26, 2026 | 75.63M |
| June 25, 2026 | 72.42M |
| June 24, 2026 | 71.18M |
| June 23, 2026 | 71.55M |
| June 22, 2026 | 75.06M |
| June 18, 2026 | 71.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 32.27B |
| PTC Therapeutics, Inc. | 5.840B |
| ACADIA Pharmaceuticals, Inc. | 5.011B |
| Alnylam Pharmaceuticals, Inc. | 31.71B |
| Anika Therapeutics, Inc. | 282.38M |
Market Cap Related Metrics
| Price to Book Value | 1.998 |
| Price | 60.78 |
| Earnings Yield | -67.25% |